iRhythm Holdings, Inc.: Needham cuts target price to $165 from $194
IRTC•Needham cut its target price for iRhythm Holdings to $165 from $194.
Related News
Ocular Therapeutix grants equity awards to eight newly hired employees
OCUL•
Genpact target price raised to $47 from $40 by BMO
G•
10X Genomics target price raised to $68 from $50 by Stifel
TXG•
Enterprise Products Partners L.P.: Stifel raises target price to $42 from $40
EPD•
Albemarle: BMO cuts target price to $160 from $175
ALB•